Please assess the completion status of the following clinical trial:

Trial Title: Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a pancreatic cyst requiring EUS-FNA to complete evaluation.~* Participant is willing and able to give informed consent for participation in the study.~* Age 18 years or older.~* Ability to understand study procedures and to comply with them for the entire length of the study.~Exclusion Criteria:~* Patients with other co-morbidities requiring antibiotic prophylaxis for endoscopic invasive procedures (such as those with cardiac valve prosthesis).~* Cystic lesion of the intestinal wall (foregut or duplication cyst).~* Use of antibiotic treatment for any other indication during the 5 days prior to the procedure.~* Pregnant woman.~* Known allergy/sensitivity to ciprofloxacin.~* Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: EXPERIMENTAL): 1 intravenous dose followed by 1 oral dose each 12 hours (complete 3 days)
- Antibiotic (Type: ACTIVE_COMPARATOR): Ciprofloxacin 400 mg intravenous one dose followed by ciprofloxacin 500 mg oral each 12 hours (complete 3 days)

Based on this trial design, predict the completion outcome and termination type (if applicable).